The Escherichia Coli
Infections therapeutics pipeline review report provides assessment information on assessment by monotherapy products, by combination products, by target, by mechanism of action, by route of administration and by molecule type.
Emergence of Escherichia coli
encoding Shiga toxin 2f in human Shiga toxin-producing E.
Inhibitory activity of gut bacteria against Escherichia coli
O157 mediated by dietary plant metabolites.
Emerging foodborne pathogens: Escherichia coli
O157:H7 as a model of entry of a new pathogen into the food supply of the developed world.
Adhesion and entry of uropathogenic Escherichia coli
Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extendedspectrum cephalosporins and cephamycins among Escherichia coli
isolates from animals and humans.
0157:H7 diarrhea in the United States: Clinical and epidemiologic features.
Shiga toxin-producing Escherichia coli
(STEC) causes sporadic outbreaks of non-bloody and bloody diarrhea, and hemolytic uremic syndrome (HUS).
Traditional enteropathogenic Escherichia coli
of infantile diarrhea.
In Saudi Arabia, Escherichia coli
isolated from chicken intestines were found to be resistant to many antibiotics such as ampicillin, chloramphenicol, gentamycin, tetracycline, trimethoprim and sulphamethoxazole (Al-Ghamdi et al.
The purpose of this experiment was to investigate on which type of cotton fabric Escherichia coli
could survive the best, and the most effective way to launder clothes.
Other reported pathogens are mycobacteria, fungi, Pneumocystis carinii, Escherichia coli
, and Salmonella typhimurium.
Further analysis showed the presence of Escherichia coli
in 10% of 50 sub samples.
The most common culprit is the bacterium Escherichia coli
, or E.
0157:H7 Outbreak at a Summer Camp, Virginia 1994.